Nuvalent (NUVL) CDO exercises options, sells 5,500 shares under 10b5-1 plan
Rhea-AI Filing Summary
Nuvalent, Inc.’s Chief Development Officer, Darlene Noci, reported a combination of option exercise and share sales in Class A Common Stock. On May 28, 2026, she exercised stock options to acquire 5,500 shares at an exercise price of $27.85 per share and sold 5,500 shares in open-market transactions.
The sales occurred in multiple trades at reported weighted average prices including $109.76, $109.30, $108.01, $107.33, and $106.26 per share. According to a footnote, these transactions were carried out under a Rule 10b5-1 trading plan adopted on November 18, 2024, indicating they were pre-arranged rather than timed discretionarily.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 5,500 | $0.00 | -- |
| Exercise | Class A Common Stock | 5,500 | $27.85 | $153K |
| Sale | Class A Common Stock | 1,300 | $106.26 | $138K |
| Sale | Class A Common Stock | 1,422 | $107.33 | $153K |
| Sale | Class A Common Stock | 1,178 | $108.01 | $127K |
| Sale | Class A Common Stock | 1,500 | $109.30 | $164K |
| Sale | Class A Common Stock | 100 | $109.76 | $11K |
Footnotes (1)
- These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2024. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.72 to $106.69, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (5) of this Form 4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.72 to $107.71, inclusive. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.72 to $108.54, inclusive. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.74 to $109.61, inclusive. The shares underlying this option have vested or shall vest over the four years following January 6, 2023 in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
Stock Option (Right to Buy) financial
Class A Common Stock financial
AI-generated analysis. How Rhea-AI works. Not financial advice.